V Wealth Advisors’s AbbVie ABBV Stock Holding History

V Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$438K	Sell	2,937 -11,606	-80%	-$1.7M	0.35%	62
2023 Q2	$1.96M	Sell	14,543 -907	-6%	-$133K	0.33%	62
2023 Q1	$2.46M	Buy	15,450 +949	+7%	+$145K	0.46%	42
2022 Q4	$2.34M	Buy	14,501 +562	+4%	+$86.2K	0.48%	41
2022 Q3	$1.87M	Sell	13,939 -197	-1%	-$28.3K	0.37%	55
2022 Q2	$2.17M	Buy	14,136 +540	+4%	+$82.5K	0.41%	47
2022 Q1	$2.2M	Sell	13,596 -1,298	-9%	-$189K	0.35%	59
2021 Q4	$2.02M	Sell	14,894 -73	-0.5%	-$8.62K	0.3%	75
2021 Q3	$1.61M	Sell	14,967 -246	-2%	-$28.1K	0.25%	92
2021 Q2	$1.72M	Sell	15,213 -1,590	-9%	-$179K	0.27%	86
2021 Q1	$1.82M	Buy	16,803 +1,296	+8%	+$139K	0.33%	67
2020 Q4	$1.66M	Buy	15,507 +11,060	+249%	+$1.06M	0.34%	66
2020 Q3	$390K	Sell	4,447 -9,662	-68%	-$910K	0.27%	96
2020 Q2	$1.39M	Buy	14,109 +1,753	+14%	+$154K	0.36%	68
2020 Q1	$941K	Buy	12,356 +2,703	+28%	+$230K	0.29%	86
2019 Q4	$731K	Hold	9,653	–	–	0.26%	104
2019 Q3	$731K	Buy	9,653 +2,474	+34%	+$170K	0.26%	104
2019 Q2	$516K	Buy	7,179 +183	+3%	+$14.4K	0.2%	125
2019 Q1	$553K	Buy	6,996 +857	+14%	+$70.1K	0.22%	112
2018 Q4	$557K	Buy	6,139 +184	+3%	+$16.2K	0.28%	91
2018 Q3	$563K	Buy	5,955 +45	+0.8%	+$4.27K	0.26%	101
2018 Q2	$585K	Buy	5,910 +6	+0.1%	+$586	0.33%	84
2018 Q1	$541K	Buy	5,904 +2,012	+52%	+$221K	0.29%	97
2017 Q4	$399K	Buy	3,892 +762	+24%	+$71.8K	0.2%	122
2017 Q3	$277K	Buy	3,130 +4	+0.1%	+$304	0.14%	140
2017 Q2	$225K	Sell	3,126 -4,612	-60%	-$310K	0.11%	165
2017 Q1	$504K	Buy	+7,738	New	+$486K	0.31%	83
2016 Q4	–	Sell	-3,946	Closed	-$248K	–	173
2016 Q3	$248K	Buy	+3,946	New	+$255K	0.2%	142

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

V Wealth Advisors's ABBV Position: Q3 2023 in Review

V Wealth Advisors reduced its AbbVie (ABBV) stake by 80% in Q3 2023, selling an estimated $1.7M and leaving 2,937 shares worth $438K. The position accounts for 0.35% of the portfolio, ranked #62.

V Wealth Advisors first reported a position in ABBV in Q3 2016 and has held it in 28 quarters since. The position peaked at $2.46M in Q1 2023. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

V Wealth Advisors held 2,937 shares of AbbVie worth $438K as of Q3 2023.
V Wealth Advisors sold 11,606 AbbVie shares in Q3 2023, an estimated $1.7M.
AbbVie made up 0.35% of V Wealth Advisors's portfolio in Q3 2023, its #62 holding.
V Wealth Advisors first reported a position in AbbVie in Q3 2016 and has held it in 28 quarters since.
V Wealth Advisors's AbbVie position peaked at $2.46M in Q1 2023.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on V Wealth Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.